7th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 19-21, 2026 | Boston, Massachusetts, USA
Naloxone
It is an opioid antagonist, which means that it inhibits or reverses the effects of opioid medications. It is mostly used to treat opioid drug overdoses due to its antagonistic properties. Naloxone binds to albumin at a rate of around 45%, although it also strongly interacts with other proteins. In order to stop the effects of opioid drugs, naloxone temporarily inhibits opioid receptors. Because naloxone cannot be used to get high, there is minimal risk that it will be taken without a prescription. There is no evidence that long-term naloxone use can have harmful physiological effects or cause dependence. Users of naloxone do not develop tolerance, and the drug is not known to have contributed to any overdose deaths. This condition primarily affects people in their 20s and 30s. The prodromal phase refers to the time before symptoms appear.
John Michael Weber
Open Door Mission in Houston Texas, United States
Frederick J Goldstein
Philadelphia College of Osteopathic Medicine, United States
Nile Stanley
University of North Florida, United States
Andrew Drasen
A Vision of Hope Media, United States
Eric Cohen
Livio Labs, United States
John Michael Weber
Open Door Mission in Houston Texas, United States
Denis Larrivee
University of Navarra, SpainSubmit your abstract Today
Title : Integrating bibliopoetry therapy and digital health technologies for inflammation management: A neuropsychosomatic perspective
Nile Stanley, University of North Florida, United States
Title : Reduction of chronic neuropathic pain by a THC-CBD combination capsule: ongoing pilot study
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Suicide prevention strategies for the law enforcement profession
Stephanie Schweitzer Dixon, SSD Consulting, United States
Title : The twelve steps beyond alcohol: Applying recovery principles to food, perfectionism, and modern behavioral addictions
Mary Dobson, Liftwell Health, United States
Title : Understanding polyvagal dysregulation, addiction, and relationships: A holistic framework for mental health and recovery
Kimberly Lannon, Your Daily Game Face, United States
Title : Kratom: Exploring its pharmacology, mental health effects, and new challenges for addiction and behavioral health experts
Kimberly Lannon, Your Daily Game Face, United States